CAMBRIDGE, MA and NEW YORK, NY--(Marketwire - February 18, 2010) -  PatientsLikeMe, the leading online community for people with life-changing conditions, is ranked #23 in Fast Company's annual issue of the 50 Most Innovative Companies in the world. The magazine honors established brands including Facebook, Cisco, Novartis and Disney along with such rising newcomers as PatientsLikeMe, Spotify, and the Indian Premier League.

PatientsLikeMe is a CommerceNet portfolio company.

Read full article.

PatientsLikeMe Inc., a Cambridge, Mass.-based company that runs an line community for people with various life-changing diseases, has acquired pain management Web site operator ReliefInsite.com LLC.

PatientsLikeMe is a CommerceNet portfolio company.

Read full article

PatientsLikeMe, the first community-based personalized medicine platform for people with life-changing conditions, and 23andMe, the world's leading personal genomics company, announce a partnership today to help people with Parkinson's disease. PatientsLikeMe is teaming with 23andMe on its effort to recruit 10,000 people with Parkinson's for a massive study of the disease, and give patients a way to learn more about their personal genetics. 

PatientsLikeMe is a CommerceNet portfolio company. 

Read full article 

Launched as a nationally and internationally syndicated program in 2003, "A World of Possibilities" is an award-winning, one-hour weekly radio program of public affairs. It seeks to build bridges across boundaries of background and belief and discover solutions to longstanding challenges through penetrating conversations with pragmatic social innovators, leading policy analysts and big-picture thinkers on key national and global issues.

To hear the recent interview with CollabRx Founder and Chairman, Dr. Jay M. Tenenbaum

NEW YORK (GenomeWeb News)--CollabRx, a San Francisco-based personalized cancer research services firm, today said that it has initiated a cancer sequencing project in collaboration with Alacris Pharmaceuticals.

Read full article 

February 26, 2009 | SAN FRANCISCO--In the powerful opening keynote at CHI's Molecular Medicine Tri-Conference on Wednesday, Jay "Marty" Tenenbaum, founder and chairman of CollabRx, urged members of the life sciences community to share their resources to empower personalized research and help satisfy the unmet medical needs of the "long tail" of disease. "As a patient...I want to tap all of the world's knowledge and all of the world's resources into curing my disease," Tenenbaum said.

Read full article 

(BUSINESS WIRE) - CollabRx, Inc. announced today the launch of its new personalized cancer research service, CollabRx ONE, designed to provide physicians with new insights into specific treatment options for their cancer patients.

Read full press release